Received Mar 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | G347X | IM / LA |
She developed progressive weakness starting on 2/26/2026 and was admitted to the hospital on 3/11/2026 and ultimately diagnosed with Guillan Barre Syndrome. She was treated with IVIG x 4 days. She was discharged from inpatient rehab on 3/18/2026 with improvement but not resolution.
None
Recurrent HSV, Major depressive disorder, osteoporosis, GERD, IBS
Acyclovir, fluoxetine
None